Auro-Azithromycin: Formulary list price $8.8208/unit (unit not stated in source; not the patient's cost)
Ministry pays: $8.8208 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=97283 · Verify on the e-Formulary ↗ (DIN 02482363)
Source record
DIN 02482363: Auro-Azithromycin
Raw flags: sec3=Y
Item: 081212025; group id 19; item number 0026; lccId None; manufacturer id AUR
Source form: O/L-15mL Pk; strength: 100mg/5mL
Recorded listing: General benefit
Source prices (unrounded): $8.8208; ministry $8.8208
Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02482363
Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=97283Interchangeable products
Sandoz Azithromycin · DIN 02332388 · $8.8208
Zithromax · DIN 02223716 · not recorded
Shortage status: resolved shortage (ended 2025-08-13); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02482363
Shortage record checked 2026-09-13T08:10:21.292534+00:00
Sandoz Azithromycin: Formulary list price $8.8208/unit (unit not stated in source; not the patient's cost)
Ministry pays: $8.8208 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=81804 · Verify on the e-Formulary ↗ (DIN 02332388)
Source record
DIN 02332388: Sandoz Azithromycin
Raw flags: sec3=Y
Item: 081212025; group id 19; item number 0026; lccId None; manufacturer id SDZ
Source form: O/L-15mL Pk; strength: 100mg/5mL
Recorded listing: General benefit
Source prices (unrounded): $8.8208; ministry $8.8208
Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02332388
Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=81804Interchangeable products
Auro-Azithromycin · DIN 02482363 · $8.8208
Zithromax · DIN 02223716 · not recorded
Shortage status: resolved shortage (ended 2023-07-10); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02332388
Shortage record checked 2026-09-13T08:10:21.292534+00:00
Auro-Azithromycin · DIN 02482371 · 200mg/5mL · oral liquid-15mL Pk
General benefitMarketed · checked 2026-09-02
StatusGeneral benefit
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Auro-Azithromycin · DIN 02482371
Manufacturer: Auro Pharma Inc.; listing date 2020-04-30
Health Canada: Marketed since 2019-10-30 · brand AURO-AZITHROMYCIN · ATC J01FA10 AZITHROMYCIN · form Powder for suspension · route Oral · ingredients AZITHROMYCIN (AZITHROMYCIN DIHYDRATE) 200 MG/5ML · company Auro pharma inc · schedule Prescription
Auro-Azithromycin: Formulary list price $12.4943/unit (unit not stated in source; not the patient's cost)
Ministry pays: $12.4943 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=97284 · Verify on the e-Formulary ↗ (DIN 02482371)
Source record
DIN 02482371: Auro-Azithromycin
Raw flags: sec3=Y
Item: 081212026; group id 19; item number 0027; lccId None; manufacturer id AUR
Source form: O/L-15mL Pk; strength: 200mg/5mL
Recorded listing: General benefit
Source prices (unrounded): $12.4943; ministry $12.4943
Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02482371
Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=97284Interchangeable products
Sandoz Azithromycin · DIN 02332396 · $12.4943
Zithromax · DIN 02223724 · not recorded
Shortage status: resolved shortage (ended 2025-04-22); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02482371
Shortage record checked 2026-09-13T08:10:21.292534+00:00
Sandoz Azithromycin: Formulary list price $12.4943/unit (unit not stated in source; not the patient's cost)
Ministry pays: $12.4943 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=81805 · Verify on the e-Formulary ↗ (DIN 02332396)
Source record
DIN 02332396: Sandoz Azithromycin
Raw flags: sec3=Y
Item: 081212026; group id 19; item number 0027; lccId None; manufacturer id SDZ
Source form: O/L-15mL Pk; strength: 200mg/5mL
Recorded listing: General benefit
Source prices (unrounded): $12.4943; ministry $12.4943
Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02332396
Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=81805Interchangeable products
Auro-Azithromycin · DIN 02482371 · $12.4943
Zithromax · DIN 02223724 · not recorded
Shortage status: resolved shortage (ended 2025-04-14); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02332396
Shortage record checked 2026-09-13T08:10:21.292534+00:00
AG-Azithromycin · DIN 02480700 · 250mg · tablet
General benefitMarketed · checked 2026-09-02
StatusGeneral benefit
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
AG-Azithromycin · DIN 02480700
Manufacturer: Angita Pharma Inc.; listing date 2020-10-30
Health Canada: Marketed since 2018-09-26 · brand AG-AZITHROMYCIN · ATC J01FA10 AZITHROMYCIN · form Tablet · route Oral · ingredients AZITHROMYCIN (AZITHROMYCIN DIHYDRATE) 250 MG · company Angita pharma inc. · schedule Prescription
AG-Azithromycin: Formulary list price $0.9410/unit (unit not stated in source; not the patient's cost)
Ministry pays: $0.9410 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=97120 · Verify on the e-Formulary ↗ (DIN 02480700)
Source record
DIN 02480700: AG-Azithromycin
Raw flags: sec3=Y
Item: 081212029; group id 19; item number 0030; lccId None; manufacturer id ANG
Source form: Tab; strength: 250mg
Recorded listing: General benefit
Source prices (unrounded): $0.9410; ministry $0.9410
Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02480700
Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=97120Interchangeable products
Apo-Azithromycin · DIN 02247423 · $0.9410
Apo-Azithromycin Z · DIN 02415542 · $0.9410
Azithromycin · DIN 02330881 · $0.9410
Azithromycin · DIN 02442434 · $0.9410
Azithromycin · DIN 02545969 · $0.9410
Jamp-Azithromycin · DIN 02452308 · $0.9410
M-Azithromycin · DIN 02502038 · $0.9410
Mar-Azithromycin · DIN 02452324 · $0.9410
NRA-Azithromycin · DIN 02479680 · $0.9410
Novo-Azithromycin · DIN 02267845 · $0.9410
PMS-Azithromycin · DIN 02261634 · $0.9410
Riva-Azithromycin · DIN 02275309 · $0.9410
Sandoz Azithromycin · DIN 02265826 · $0.9410
Zithromax · DIN 02212021 · not recorded
Shortage status: no shortage or discontinuation reported (checked 2026-09-13T08:10:21.292534+00:00); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02480700
Shortage record checked 2026-09-13T08:10:21.292534+00:00
Apo-Azithromycin Z · DIN 02415542 · 250mg · tablet
General benefitMarketed · checked 2026-09-02
StatusGeneral benefit
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Apo-Azithromycin Z · DIN 02415542
Manufacturer: Apotex Inc.; listing date 2014-01-30
Health Canada: Marketed since 2014-03-06 · brand APO-AZITHROMYCIN Z · ATC J01FA10 AZITHROMYCIN · form Tablet · route Oral · ingredients AZITHROMYCIN (AZITHROMYCIN DIHYDRATE) 250 MG · company Apotex inc · schedule Prescription
Apo-Azithromycin Z: Formulary list price $0.9410/unit (unit not stated in source; not the patient's cost)
Ministry pays: $0.9410 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=90013 · Verify on the e-Formulary ↗ (DIN 02415542)
Source record
DIN 02415542: Apo-Azithromycin Z
Raw flags: sec3=Y
Item: 081212029; group id 19; item number 0030; lccId None; manufacturer id APX
Source form: Tab; strength: 250mg
Recorded listing: General benefit
Source prices (unrounded): $0.9410; ministry $0.9410
Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02415542
Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=90013Interchangeable products
AG-Azithromycin · DIN 02480700 · $0.9410
Apo-Azithromycin · DIN 02247423 · $0.9410
Azithromycin · DIN 02330881 · $0.9410
Azithromycin · DIN 02442434 · $0.9410
Azithromycin · DIN 02545969 · $0.9410
Jamp-Azithromycin · DIN 02452308 · $0.9410
M-Azithromycin · DIN 02502038 · $0.9410
Mar-Azithromycin · DIN 02452324 · $0.9410
NRA-Azithromycin · DIN 02479680 · $0.9410
Novo-Azithromycin · DIN 02267845 · $0.9410
PMS-Azithromycin · DIN 02261634 · $0.9410
Riva-Azithromycin · DIN 02275309 · $0.9410
Sandoz Azithromycin · DIN 02265826 · $0.9410
Zithromax · DIN 02212021 · not recorded
Shortage status: resolved shortage (ended 2024-10-31); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02415542
Shortage record checked 2026-09-13T08:10:21.292534+00:00
Azithromycin · DIN 02330881 · 250mg · tablet
General benefitMarketed · checked 2026-09-02
StatusGeneral benefit
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Azithromycin · DIN 02330881
Manufacturer: Sanis Health Inc.; listing date 2011-08-04
Health Canada: Marketed since 2017-08-11 · brand AZITHROMYCIN · ATC J01FA10 AZITHROMYCIN · form Tablet · route Oral · ingredients AZITHROMYCIN (AZITHROMYCIN DIHYDRATE) 250 MG · company Sanis health inc · schedule Prescription
Azithromycin: Formulary list price $0.9410/unit (unit not stated in source; not the patient's cost)
Ministry pays: $0.9410 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=81664 · Verify on the e-Formulary ↗ (DIN 02330881)
Source record
DIN 02330881: Azithromycin
Raw flags: sec3=Y
Item: 081212029; group id 19; item number 0030; lccId None; manufacturer id SAI
Source form: Tab; strength: 250mg
Recorded listing: General benefit
Source prices (unrounded): $0.9410; ministry $0.9410
Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02330881
Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=81664Interchangeable products
AG-Azithromycin · DIN 02480700 · $0.9410
Apo-Azithromycin · DIN 02247423 · $0.9410
Apo-Azithromycin Z · DIN 02415542 · $0.9410
Azithromycin · DIN 02442434 · $0.9410
Azithromycin · DIN 02545969 · $0.9410
Jamp-Azithromycin · DIN 02452308 · $0.9410
M-Azithromycin · DIN 02502038 · $0.9410
Mar-Azithromycin · DIN 02452324 · $0.9410
NRA-Azithromycin · DIN 02479680 · $0.9410
Novo-Azithromycin · DIN 02267845 · $0.9410
PMS-Azithromycin · DIN 02261634 · $0.9410
Riva-Azithromycin · DIN 02275309 · $0.9410
Sandoz Azithromycin · DIN 02265826 · $0.9410
Zithromax · DIN 02212021 · not recorded
Shortage status: resolved shortage (ended 2026-06-03); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02330881
Shortage record checked 2026-09-13T08:10:21.292534+00:00
Azithromycin · DIN 02442434 · 250mg · tablet
General benefitMarketed · checked 2026-09-02
StatusGeneral benefit
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Azithromycin · DIN 02442434
Manufacturer: Sivem Pharmaceuticals ULC; listing date 2020-04-30
Health Canada: Marketed since 2018-01-05 · brand AZITHROMYCIN · ATC J01FA10 AZITHROMYCIN · form Tablet · route Oral · ingredients AZITHROMYCIN (AZITHROMYCIN DIHYDRATE) 250 MG · company Sivem pharmaceuticals ulc · schedule Prescription
Azithromycin: Formulary list price $0.9410/unit (unit not stated in source; not the patient's cost)
Ministry pays: $0.9410 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=92678 · Verify on the e-Formulary ↗ (DIN 02442434)
Source record
DIN 02442434: Azithromycin
Raw flags: sec3=Y
Item: 081212029; group id 19; item number 0030; lccId None; manufacturer id SIV
Source form: Tab; strength: 250mg
Recorded listing: General benefit
Source prices (unrounded): $0.9410; ministry $0.9410
Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02442434
Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=92678Interchangeable products
AG-Azithromycin · DIN 02480700 · $0.9410
Apo-Azithromycin · DIN 02247423 · $0.9410
Apo-Azithromycin Z · DIN 02415542 · $0.9410
Azithromycin · DIN 02330881 · $0.9410
Azithromycin · DIN 02545969 · $0.9410
Jamp-Azithromycin · DIN 02452308 · $0.9410
M-Azithromycin · DIN 02502038 · $0.9410
Mar-Azithromycin · DIN 02452324 · $0.9410
NRA-Azithromycin · DIN 02479680 · $0.9410
Novo-Azithromycin · DIN 02267845 · $0.9410
PMS-Azithromycin · DIN 02261634 · $0.9410
Riva-Azithromycin · DIN 02275309 · $0.9410
Sandoz Azithromycin · DIN 02265826 · $0.9410
Zithromax · DIN 02212021 · not recorded
Shortage status: resolved shortage (ended 2025-05-12); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02442434
Shortage record checked 2026-09-13T08:10:21.292534+00:00
Azithromycin · DIN 02545969 · 250mg · tablet
General benefitMarketed · checked 2026-09-02
StatusGeneral benefit
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Azithromycin · DIN 02545969
Manufacturer: DAC Pharmaceuticals; listing date 2026-02-27
Health Canada: Marketed since 2025-02-26 · brand AZITHROMYCIN · ATC J01FA10 AZITHROMYCIN · form Tablet · route Oral · ingredients AZITHROMYCIN (AZITHROMYCIN DIHYDRATE) 250 MG · company 10445517 canada inc / north pharmaceuticals / dac pharmaceuticals · schedule Prescription
Azithromycin: Formulary list price $0.9410/unit (unit not stated in source; not the patient's cost)
Ministry pays: $0.9410 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=103468 · Verify on the e-Formulary ↗ (DIN 02545969)
Source record
DIN 02545969: Azithromycin
Raw flags: sec3=Y
Item: 081212029; group id 19; item number 0030; lccId None; manufacturer id DAC
Source form: Tab; strength: 250mg
Recorded listing: General benefit
Source prices (unrounded): $0.9410; ministry $0.9410
Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02545969
Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=103468Interchangeable products
AG-Azithromycin · DIN 02480700 · $0.9410
Apo-Azithromycin · DIN 02247423 · $0.9410
Apo-Azithromycin Z · DIN 02415542 · $0.9410
Azithromycin · DIN 02330881 · $0.9410
Azithromycin · DIN 02442434 · $0.9410
Jamp-Azithromycin · DIN 02452308 · $0.9410
M-Azithromycin · DIN 02502038 · $0.9410
Mar-Azithromycin · DIN 02452324 · $0.9410
NRA-Azithromycin · DIN 02479680 · $0.9410
Novo-Azithromycin · DIN 02267845 · $0.9410
PMS-Azithromycin · DIN 02261634 · $0.9410
Riva-Azithromycin · DIN 02275309 · $0.9410
Sandoz Azithromycin · DIN 02265826 · $0.9410
Zithromax · DIN 02212021 · not recorded
Shortage status: no shortage or discontinuation reported (checked 2026-09-13T08:10:21.292534+00:00); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02545969
Shortage record checked 2026-09-13T08:10:21.292534+00:00
Jamp-Azithromycin · DIN 02452308 · 250mg · tablet
General benefitMarketed · checked 2026-09-02
StatusGeneral benefit
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Jamp-Azithromycin · DIN 02452308
Manufacturer: Jamp Pharma Corporation; listing date 2016-11-30
Health Canada: Marketed since 2016-09-29 · brand JAMP-AZITHROMYCIN · ATC J01FA10 AZITHROMYCIN · form Tablet · route Oral · ingredients AZITHROMYCIN (AZITHROMYCIN DIHYDRATE) 250 MG · company Jamp pharma corporation · schedule Prescription
Jamp-Azithromycin: Formulary list price $0.9410/unit (unit not stated in source; not the patient's cost)
Ministry pays: $0.9410 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=93868 · Verify on the e-Formulary ↗ (DIN 02452308)
Source record
DIN 02452308: Jamp-Azithromycin
Raw flags: sec3=Y
Item: 081212029; group id 19; item number 0030; lccId None; manufacturer id JPC
Source form: Tab; strength: 250mg
Recorded listing: General benefit
Source prices (unrounded): $0.9410; ministry $0.9410
Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02452308
Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=93868Interchangeable products
AG-Azithromycin · DIN 02480700 · $0.9410
Apo-Azithromycin · DIN 02247423 · $0.9410
Apo-Azithromycin Z · DIN 02415542 · $0.9410
Azithromycin · DIN 02330881 · $0.9410
Azithromycin · DIN 02442434 · $0.9410
Azithromycin · DIN 02545969 · $0.9410
M-Azithromycin · DIN 02502038 · $0.9410
Mar-Azithromycin · DIN 02452324 · $0.9410
NRA-Azithromycin · DIN 02479680 · $0.9410
Novo-Azithromycin · DIN 02267845 · $0.9410
PMS-Azithromycin · DIN 02261634 · $0.9410
Riva-Azithromycin · DIN 02275309 · $0.9410
Sandoz Azithromycin · DIN 02265826 · $0.9410
Zithromax · DIN 02212021 · not recorded
Shortage status: resolved shortage (ended 2025-04-09); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02452308
Shortage record checked 2026-09-13T08:10:21.292534+00:00
M-Azithromycin · DIN 02502038 · 250mg · tablet
General benefitMarketed · checked 2026-09-02
StatusGeneral benefit
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
M-Azithromycin · DIN 02502038
Manufacturer: Mantra Pharma Inc.; listing date 2021-08-31
Health Canada: Marketed since 2021-01-19 · brand M-AZITHROMYCIN · ATC J01FA10 AZITHROMYCIN · form Tablet · route Oral · ingredients AZITHROMYCIN (AZITHROMYCIN DIHYDRATE) 250 MG · company Mantra pharma inc · schedule Prescription
M-Azithromycin: Formulary list price $0.9410/unit (unit not stated in source; not the patient's cost)
Ministry pays: $0.9410 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=99162 · Verify on the e-Formulary ↗ (DIN 02502038)
Source record
DIN 02502038: M-Azithromycin
Raw flags: sec3=Y
Item: 081212029; group id 19; item number 0030; lccId None; manufacturer id MAT
Source form: Tab; strength: 250mg
Recorded listing: General benefit
Source prices (unrounded): $0.9410; ministry $0.9410
Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02502038
Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=99162Interchangeable products
AG-Azithromycin · DIN 02480700 · $0.9410
Apo-Azithromycin · DIN 02247423 · $0.9410
Apo-Azithromycin Z · DIN 02415542 · $0.9410
Azithromycin · DIN 02330881 · $0.9410
Azithromycin · DIN 02442434 · $0.9410
Azithromycin · DIN 02545969 · $0.9410
Jamp-Azithromycin · DIN 02452308 · $0.9410
Mar-Azithromycin · DIN 02452324 · $0.9410
NRA-Azithromycin · DIN 02479680 · $0.9410
Novo-Azithromycin · DIN 02267845 · $0.9410
PMS-Azithromycin · DIN 02261634 · $0.9410
Riva-Azithromycin · DIN 02275309 · $0.9410
Sandoz Azithromycin · DIN 02265826 · $0.9410
Zithromax · DIN 02212021 · not recorded
Shortage status: resolved shortage (ended 2025-03-24); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02502038
Shortage record checked 2026-09-13T08:10:21.292534+00:00
Mar-Azithromycin · DIN 02452324 · 250mg · tablet
General benefitMarketed · checked 2026-09-02
StatusGeneral benefit
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Mar-Azithromycin · DIN 02452324
Manufacturer: Marcan Pharmaceuticals Inc.; listing date 2016-11-30
Health Canada: Marketed since 2023-03-31 · brand MAR-AZITHROMYCIN · ATC J01FA10 AZITHROMYCIN · form Tablet · route Oral · ingredients AZITHROMYCIN (AZITHROMYCIN DIHYDRATE) 250 MG · company Marcan pharmaceuticals inc · schedule Prescription
Mar-Azithromycin: Formulary list price $0.9410/unit (unit not stated in source; not the patient's cost)
Ministry pays: $0.9410 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=93870 · Verify on the e-Formulary ↗ (DIN 02452324)
Source record
DIN 02452324: Mar-Azithromycin
Raw flags: sec3=Y
Item: 081212029; group id 19; item number 0030; lccId None; manufacturer id MAR
Source form: Tab; strength: 250mg
Recorded listing: General benefit
Source prices (unrounded): $0.9410; ministry $0.9410
Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02452324
Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=93870Interchangeable products
AG-Azithromycin · DIN 02480700 · $0.9410
Apo-Azithromycin · DIN 02247423 · $0.9410
Apo-Azithromycin Z · DIN 02415542 · $0.9410
Azithromycin · DIN 02330881 · $0.9410
Azithromycin · DIN 02442434 · $0.9410
Azithromycin · DIN 02545969 · $0.9410
Jamp-Azithromycin · DIN 02452308 · $0.9410
M-Azithromycin · DIN 02502038 · $0.9410
NRA-Azithromycin · DIN 02479680 · $0.9410
Novo-Azithromycin · DIN 02267845 · $0.9410
PMS-Azithromycin · DIN 02261634 · $0.9410
Riva-Azithromycin · DIN 02275309 · $0.9410
Sandoz Azithromycin · DIN 02265826 · $0.9410
Zithromax · DIN 02212021 · not recorded
Shortage status: resolved shortage (ended 2023-06-01); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02452324
Shortage record checked 2026-09-13T08:10:21.292534+00:00
NRA-Azithromycin · DIN 02479680 · 250mg · tablet
General benefitMarketed · checked 2026-09-02
StatusGeneral benefit
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
NRA-Azithromycin · DIN 02479680
Manufacturer: Nora Pharma; listing date 2020-06-30
Health Canada: Marketed since 2019-05-07 · brand NRA-AZITHROMYCIN · ATC J01FA10 AZITHROMYCIN · form Tablet · route Oral · ingredients AZITHROMYCIN (AZITHROMYCIN DIHYDRATE) 250 MG · company Nora pharma inc · schedule Prescription
NRA-Azithromycin: Formulary list price $0.9410/unit (unit not stated in source; not the patient's cost)
Ministry pays: $0.9410 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=96991 · Verify on the e-Formulary ↗ (DIN 02479680)
Source record
DIN 02479680: NRA-Azithromycin
Raw flags: sec3=Y
Item: 081212029; group id 19; item number 0030; lccId None; manufacturer id NRA
Source form: Tab; strength: 250mg
Recorded listing: General benefit
Source prices (unrounded): $0.9410; ministry $0.9410
Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02479680
Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=96991Interchangeable products
AG-Azithromycin · DIN 02480700 · $0.9410
Apo-Azithromycin · DIN 02247423 · $0.9410
Apo-Azithromycin Z · DIN 02415542 · $0.9410
Azithromycin · DIN 02330881 · $0.9410
Azithromycin · DIN 02442434 · $0.9410
Azithromycin · DIN 02545969 · $0.9410
Jamp-Azithromycin · DIN 02452308 · $0.9410
M-Azithromycin · DIN 02502038 · $0.9410
Mar-Azithromycin · DIN 02452324 · $0.9410
Novo-Azithromycin · DIN 02267845 · $0.9410
PMS-Azithromycin · DIN 02261634 · $0.9410
Riva-Azithromycin · DIN 02275309 · $0.9410
Sandoz Azithromycin · DIN 02265826 · $0.9410
Zithromax · DIN 02212021 · not recorded
Shortage status: no shortage or discontinuation reported (checked 2026-09-13T08:10:21.292534+00:00); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02479680
Shortage record checked 2026-09-13T08:10:21.292534+00:00
Novo-Azithromycin · DIN 02267845 · 250mg · tablet
General benefitMarketed · checked 2026-09-02
StatusGeneral benefit
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Novo-Azithromycin · DIN 02267845
Manufacturer: Novopharm Ltd.; listing date 2006-01-24
Health Canada: Marketed since 2017-03-03 · brand TEVA-AZITHROMYCIN · ATC J01FA10 AZITHROMYCIN · form Tablet · route Oral · ingredients AZITHROMYCIN (AZITHROMYCIN MONOHYDRATE HEMIETHANOLATE) 250 MG · company Teva canada limited · schedule Prescription
Novo-Azithromycin: Formulary list price $0.9410/unit (unit not stated in source; not the patient's cost)
Ministry pays: $0.9410 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=75325 · Verify on the e-Formulary ↗ (DIN 02267845)
Source record
DIN 02267845: Novo-Azithromycin
Raw flags: sec3=Y
Item: 081212029; group id 19; item number 0030; lccId None; manufacturer id NOP
Source form: Tab; strength: 250mg
Recorded listing: General benefit
Source prices (unrounded): $0.9410; ministry $0.9410
Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02267845
Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=75325Interchangeable products
AG-Azithromycin · DIN 02480700 · $0.9410
Apo-Azithromycin · DIN 02247423 · $0.9410
Apo-Azithromycin Z · DIN 02415542 · $0.9410
Azithromycin · DIN 02330881 · $0.9410
Azithromycin · DIN 02442434 · $0.9410
Azithromycin · DIN 02545969 · $0.9410
Jamp-Azithromycin · DIN 02452308 · $0.9410
M-Azithromycin · DIN 02502038 · $0.9410
Mar-Azithromycin · DIN 02452324 · $0.9410
NRA-Azithromycin · DIN 02479680 · $0.9410
PMS-Azithromycin · DIN 02261634 · $0.9410
Riva-Azithromycin · DIN 02275309 · $0.9410
Sandoz Azithromycin · DIN 02265826 · $0.9410
Zithromax · DIN 02212021 · not recorded
Shortage status: discontinued (2025-04-07, reported by TEVA CANADA LIMITED); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02267845
Shortage record checked 2026-09-13T08:10:21.292534+00:00
PMS-Azithromycin · DIN 02261634 · 250mg · tablet
General benefitMarketed · checked 2026-09-02
StatusGeneral benefit
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
PMS-Azithromycin · DIN 02261634
Manufacturer: Pharmascience Inc.; listing date 2006-03-01
Health Canada: Marketed since 2006-01-04 · brand PMS-AZITHROMYCIN · ATC J01FA10 AZITHROMYCIN · form Tablet · route Oral · ingredients AZITHROMYCIN 250 MG · company Pharmascience inc · schedule Prescription
PMS-Azithromycin: Formulary list price $0.9410/unit (unit not stated in source; not the patient's cost)
Ministry pays: $0.9410 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=74701 · Verify on the e-Formulary ↗ (DIN 02261634)
Source record
DIN 02261634: PMS-Azithromycin
Raw flags: sec3=Y
Item: 081212029; group id 19; item number 0030; lccId None; manufacturer id PMS
Source form: Tab; strength: 250mg
Recorded listing: General benefit
Source prices (unrounded): $0.9410; ministry $0.9410
Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02261634
Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=74701Interchangeable products
AG-Azithromycin · DIN 02480700 · $0.9410
Apo-Azithromycin · DIN 02247423 · $0.9410
Apo-Azithromycin Z · DIN 02415542 · $0.9410
Azithromycin · DIN 02330881 · $0.9410
Azithromycin · DIN 02442434 · $0.9410
Azithromycin · DIN 02545969 · $0.9410
Jamp-Azithromycin · DIN 02452308 · $0.9410
M-Azithromycin · DIN 02502038 · $0.9410
Mar-Azithromycin · DIN 02452324 · $0.9410
NRA-Azithromycin · DIN 02479680 · $0.9410
Novo-Azithromycin · DIN 02267845 · $0.9410
Riva-Azithromycin · DIN 02275309 · $0.9410
Sandoz Azithromycin · DIN 02265826 · $0.9410
Zithromax · DIN 02212021 · not recorded
Shortage status: resolved shortage (ended 2024-12-15); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02261634
Shortage record checked 2026-09-13T08:10:21.292534+00:00
Riva-Azithromycin · DIN 02275309 · 250mg · tablet
General benefitMarketed · checked 2026-09-02
StatusGeneral benefit
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Riva-Azithromycin · DIN 02275309
Manufacturer: Laboratoire Riva Inc.; listing date 2021-08-31
Health Canada: Marketed since 2024-06-18 · brand RIVA-AZITHROMYCIN · ATC J01FA10 AZITHROMYCIN · form Tablet · route Oral · ingredients AZITHROMYCIN (AZITHROMYCIN DIHYDRATE) 250 MG · company Laboratoire riva inc. · schedule Prescription
Riva-Azithromycin: Formulary list price $0.9410/unit (unit not stated in source; not the patient's cost)
Ministry pays: $0.9410 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=76094 · Verify on the e-Formulary ↗ (DIN 02275309)
Source record
DIN 02275309: Riva-Azithromycin
Raw flags: sec3=Y
Item: 081212029; group id 19; item number 0030; lccId None; manufacturer id RIA
Source form: Tab; strength: 250mg
Recorded listing: General benefit
Source prices (unrounded): $0.9410; ministry $0.9410
Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02275309
Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=76094Interchangeable products
AG-Azithromycin · DIN 02480700 · $0.9410
Apo-Azithromycin · DIN 02247423 · $0.9410
Apo-Azithromycin Z · DIN 02415542 · $0.9410
Azithromycin · DIN 02330881 · $0.9410
Azithromycin · DIN 02442434 · $0.9410
Azithromycin · DIN 02545969 · $0.9410
Jamp-Azithromycin · DIN 02452308 · $0.9410
M-Azithromycin · DIN 02502038 · $0.9410
Mar-Azithromycin · DIN 02452324 · $0.9410
NRA-Azithromycin · DIN 02479680 · $0.9410
Novo-Azithromycin · DIN 02267845 · $0.9410
PMS-Azithromycin · DIN 02261634 · $0.9410
Sandoz Azithromycin · DIN 02265826 · $0.9410
Zithromax · DIN 02212021 · not recorded
Shortage status: no shortage or discontinuation reported (checked 2026-09-13T08:10:21.292534+00:00); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02275309
Shortage record checked 2026-09-13T08:10:21.292534+00:00
Sandoz Azithromycin · DIN 02265826 · 250mg · tablet
General benefitMarketed · checked 2026-09-02
StatusGeneral benefit
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Sandoz Azithromycin · DIN 02265826
Manufacturer: Sandoz Canada Inc.; listing date 2006-01-24
Health Canada: Marketed since 2016-03-11 · brand SANDOZ AZITHROMYCIN · ATC J01FA10 AZITHROMYCIN · form Tablet · route Oral · ingredients AZITHROMYCIN (AZITHROMYCIN DIHYDRATE) 250 MG · company Sandoz canada incorporated · schedule Prescription
Sandoz Azithromycin: Formulary list price $0.9410/unit (unit not stated in source; not the patient's cost)
Ministry pays: $0.9410 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=75127 · Verify on the e-Formulary ↗ (DIN 02265826)
Source record
DIN 02265826: Sandoz Azithromycin
Raw flags: sec3=Y
Item: 081212029; group id 19; item number 0030; lccId None; manufacturer id SDZ
Source form: Tab; strength: 250mg
Recorded listing: General benefit
Source prices (unrounded): $0.9410; ministry $0.9410
Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02265826
Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=75127Interchangeable products
AG-Azithromycin · DIN 02480700 · $0.9410
Apo-Azithromycin · DIN 02247423 · $0.9410
Apo-Azithromycin Z · DIN 02415542 · $0.9410
Azithromycin · DIN 02330881 · $0.9410
Azithromycin · DIN 02442434 · $0.9410
Azithromycin · DIN 02545969 · $0.9410
Jamp-Azithromycin · DIN 02452308 · $0.9410
M-Azithromycin · DIN 02502038 · $0.9410
Mar-Azithromycin · DIN 02452324 · $0.9410
NRA-Azithromycin · DIN 02479680 · $0.9410
Novo-Azithromycin · DIN 02267845 · $0.9410
PMS-Azithromycin · DIN 02261634 · $0.9410
Riva-Azithromycin · DIN 02275309 · $0.9410
Zithromax · DIN 02212021 · not recorded
Shortage status: resolved shortage (ended 2025-07-21); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02265826
Shortage record checked 2026-09-13T08:10:21.292534+00:00
PMS-Azithromycin · DIN 02261642 · 600mg · tablet
Limited Use — Reason for Use code 549 requiredDormant since 2026-07-31 · checked 2026-09-02 · What does dormant mean?
StatusLimited Use — Reason for Use code 549 required
Write on scriptLU code 549 (patient must meet the criteria below)
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
Ontario Limited Use criteria — code 549
Reason for Use code 549
For the prevention of disseminated Mycobacterium avium complex (MAC) disease in persons with advanced HIV infections.
Coverage limit:
LU Authorization Period: 1 year
1 brand, same coverage
PMS-Azithromycin · DIN 02261642
Manufacturer: Pharmascience Inc.; listing date 2011-10-25
Health Canada: Dormant since 2026-07-31 · brand PMS-AZITHROMYCIN · ATC J01FA10 AZITHROMYCIN · form Tablet · route Oral · ingredients AZITHROMYCIN 600 MG · company Pharmascience inc · schedule Prescription
PMS-Azithromycin: Formulary list price $10.6652/unit (unit not stated in source; not the patient's cost)
Ministry pays: $10.6652 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=74702 · Verify on the e-Formulary ↗ (DIN 02261642)
Source record
DIN 02261642: PMS-Azithromycin
Raw flags: sec12=Y, sec3=Y
Item: 081212028; group id 20; item number 0031; lccId 00313; manufacturer id PMS
Source form: Tab; strength: 600mg
Recorded listing: Limited Use: paid only with a Reason for Use code and the criteria below
Source prices (unrounded): $10.6652; ministry $10.6652
Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02261642
Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=74702Interchangeable products
Zithromax · DIN 02231143 · not recorded
Shortage status: resolved shortage (ended 2023-05-15); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02261642
Shortage record checked 2026-09-13T08:10:21.292534+00:00
Health Canada lists this DIN as Dormant since 2026-07-31 — choose a marketed DIN from the same-category list.
General benefitOntario PIN; no Health Canada record under this code
StatusGeneral benefit
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
No Health Canada record under this code: Ontario lists it under a product identification number (PIN), not a DIN.
Look up the brand's own DIN on Health Canada: https://health-products.canada.ca/dpd-bdpp/index-eng.jsp
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Auro-Azithromycin · DIN 09857636
Manufacturer: Auro Pharma Inc.; listing date 2020-04-30
No Health Canada record under this code: Ontario lists it under a product identification number (PIN), not a DIN.
Look up the brand's own DIN on Health Canada: https://health-products.canada.ca/dpd-bdpp/index-eng.jsp
DIN 09857636: Auro-Azithromycin
Raw flags: sec3=Y
Item: 081212036; group id 19; item number 0028; lccId None; manufacturer id AUR
Source form: O/L-22.5mL Pk; strength: 200mg/5mL
Recorded listing: General benefit
Source prices (unrounded): $18.7425; ministry $18.7425
Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=09857636
Look up the brand's own DIN on Health Canada: https://health-products.canada.ca/dpd-bdpp/index-eng.jspInterchangeable products
Sandoz Azithromycin · DIN 09857351 · $18.7425
Zithromax · DIN 09857315 · not recorded
Shortage status: no shortage or discontinuation reported (checked 2026-09-13T08:10:21.292534+00:00); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=09857636
Shortage record checked 2026-09-13T08:10:21.292534+00:00
General benefitOntario PIN; no Health Canada record under this code
StatusGeneral benefit
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
No Health Canada record under this code: Ontario lists it under a product identification number (PIN), not a DIN.
Look up the brand's own DIN on Health Canada: https://health-products.canada.ca/dpd-bdpp/index-eng.jsp
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Sandoz Azithromycin · DIN 09857351
Manufacturer: Sandoz Canada Inc.; listing date 2010-04-23
No Health Canada record under this code: Ontario lists it under a product identification number (PIN), not a DIN.
Look up the brand's own DIN on Health Canada: https://health-products.canada.ca/dpd-bdpp/index-eng.jsp
DIN 09857351: Sandoz Azithromycin
Raw flags: sec3=Y
Item: 081212036; group id 19; item number 0028; lccId None; manufacturer id SDZ
Source form: O/L-22.5mL Pk; strength: 200mg/5mL
Recorded listing: General benefit
Source prices (unrounded): $18.7425; ministry $18.7425
Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=09857351
Look up the brand's own DIN on Health Canada: https://health-products.canada.ca/dpd-bdpp/index-eng.jspInterchangeable products
Auro-Azithromycin · DIN 09857636 · $18.7425
Zithromax · DIN 09857315 · not recorded
Shortage status: no shortage or discontinuation reported (checked 2026-09-13T08:10:21.292534+00:00); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=09857351
Shortage record checked 2026-09-13T08:10:21.292534+00:00
General benefitOntario PIN; no Health Canada record under this code
StatusGeneral benefit
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
No Health Canada record under this code: Ontario lists it under a product identification number (PIN), not a DIN.
Look up the brand's own DIN on Health Canada: https://health-products.canada.ca/dpd-bdpp/index-eng.jsp
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Auro-Azithromycin · DIN 09857638
Manufacturer: Auro Pharma Inc.; listing date 2020-05-29
No Health Canada record under this code: Ontario lists it under a product identification number (PIN), not a DIN.
Look up the brand's own DIN on Health Canada: https://health-products.canada.ca/dpd-bdpp/index-eng.jsp
DIN 09857638: Auro-Azithromycin
Raw flags: sec3=Y
Item: 081212041; group id 19; item number 0029; lccId None; manufacturer id AUR
Source form: O/L-37.5mL Pk; strength: 200mg/5mL
Recorded listing: General benefit
Source prices (unrounded): $31.2375; ministry $31.2375
Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=09857638
Look up the brand's own DIN on Health Canada: https://health-products.canada.ca/dpd-bdpp/index-eng.jsp
Therapeutic Notes (formulary)
Zithromax 200mg/5mL oral solution is not commercially available in the 37.5mL pack size and it is only shown in this interchangeable category to facilitate the interchangeability designation with Auro-Azithromycin 200mg/5mL - 37.5mL pack.Interchangeable products
Zithromax · DIN 09857637 · not recorded
Shortage status: no shortage or discontinuation reported (checked 2026-09-13T08:10:21.292534+00:00); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=09857638
Shortage record checked 2026-09-13T08:10:21.292534+00:00
Listed, not a benefitOntario PIN; no Health Canada record under this code
StatusListed, not a benefit
Write on scriptnot a benefit; no Exceptional Access criteria on record; see alternatives
Patient paysPatient pays: program not supplied; amount cannot be determined.
No Health Canada record under this code: Ontario lists it under a product identification number (PIN), not a DIN.
Look up the brand's own DIN on Health Canada: https://health-products.canada.ca/dpd-bdpp/index-eng.jsp
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Zithromax · DIN 09857315
Manufacturer: Pfizer Canada Inc.; listing date 2009-03-02
No Health Canada record under this code: Ontario lists it under a product identification number (PIN), not a DIN.
Look up the brand's own DIN on Health Canada: https://health-products.canada.ca/dpd-bdpp/index-eng.jsp
DIN 09857315: Zithromax
Raw flags: notABenefit=Y, sec3=Y
Item: 081212036; group id 19; item number 0028; lccId None; manufacturer id PFI
Source form: O/L-22.5mL Pk; strength: 200mg/5mL
Recorded listing: Listed, not a benefit; ODB pays only for the benefit products in this interchangeable category
Source prices (unrounded): not recorded; ministry not recorded
Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=09857315
Look up the brand's own DIN on Health Canada: https://health-products.canada.ca/dpd-bdpp/index-eng.jspInterchangeable products
Auro-Azithromycin · DIN 09857636 · $18.7425
Sandoz Azithromycin · DIN 09857351 · $18.7425
Shortage status: no shortage or discontinuation reported (checked 2026-09-13T08:10:21.292534+00:00); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=09857315
Shortage record checked 2026-09-13T08:10:21.292534+00:00
Listed, not a benefitOntario PIN; no Health Canada record under this code
StatusListed, not a benefit
Write on scriptnot a benefit; no Exceptional Access criteria on record; see alternatives
Patient paysPatient pays: program not supplied; amount cannot be determined.
No Health Canada record under this code: Ontario lists it under a product identification number (PIN), not a DIN.
Look up the brand's own DIN on Health Canada: https://health-products.canada.ca/dpd-bdpp/index-eng.jsp
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Zithromax · DIN 09857637
Manufacturer: Pfizer Canada Inc.; listing date 2020-05-29
No Health Canada record under this code: Ontario lists it under a product identification number (PIN), not a DIN.
Look up the brand's own DIN on Health Canada: https://health-products.canada.ca/dpd-bdpp/index-eng.jsp
DIN 09857637: Zithromax
Raw flags: notABenefit=Y, sec3=Y
Item: 081212041; group id 19; item number 0029; lccId None; manufacturer id PFI
Source form: O/L-37.5mL Pk; strength: 200mg/5mL
Recorded listing: Listed, not a benefit; ODB pays only for the benefit products in this interchangeable category
Source prices (unrounded): not recorded; ministry not recorded
Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=09857637
Look up the brand's own DIN on Health Canada: https://health-products.canada.ca/dpd-bdpp/index-eng.jsp
Therapeutic Notes (formulary)
Zithromax 200mg/5mL oral solution is not commercially available in the 37.5mL pack size and it is only shown in this interchangeable category to facilitate the interchangeability designation with Auro-Azithromycin 200mg/5mL - 37.5mL pack.Interchangeable products
Auro-Azithromycin · DIN 09857638 · $31.2375
Shortage status: no shortage or discontinuation reported (checked 2026-09-13T08:10:21.292534+00:00); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=09857637
Shortage record checked 2026-09-13T08:10:21.292534+00:00
Zithromax · DIN 02223716 · 100mg/5mL · oral liquid-15mL Pk
Listed, not a benefit; Health Canada lists this DIN as Cancelled post market since 2025-06-27 — choose a marketed DIN from the same-category list.Discontinued 2025-06-27 · checked 2026-09-02
StatusListed, not a benefit; Health Canada lists this DIN as Cancelled post market since 2025-06-27 — choose a marketed DIN from the same-category list.
Write on scriptnot a benefit; no Exceptional Access criteria on record; see alternatives; Health Canada lists this DIN as Cancelled post market since 2025-06-27 — choose a marketed DIN from the same-category list.
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Zithromax · DIN 02223716
Manufacturer: Pfizer Canada Inc.; listing date 1997-08-28
Health Canada: Cancelled post market since 2025-06-27 · brand ZITHROMAX - PWS ORL 100MG/5ML · ATC J01FA10 AZITHROMYCIN · form Powder for suspension · route Oral · ingredients AZITHROMYCIN 100 MG/5ML · company Pfizer canada ulc · schedule Prescription
Zithromax: Formulary list price not recorded/unit (unit not stated in source; not the patient's cost)
Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=43386 · Verify on the e-Formulary ↗ (DIN 02223716)
Source record
DIN 02223716: Zithromax
Raw flags: notABenefit=Y, sec3=Y
Item: 081212025; group id 19; item number 0026; lccId None; manufacturer id PFI
Source form: O/L-15mL Pk; strength: 100mg/5mL
Recorded listing: Listed, not a benefit; ODB pays only for the benefit products in this interchangeable category
Source prices (unrounded): not recorded; ministry not recorded
Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02223716
Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=43386Interchangeable products
Auro-Azithromycin · DIN 02482363 · $8.8208
Sandoz Azithromycin · DIN 02332388 · $8.8208
Shortage status: active shortage (reported not recorded, last updated 2023-01-30) — report may be stale, confirm; reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02223716
Shortage record checked 2026-09-13T08:10:21.292534+00:00
Health Canada lists this DIN as Cancelled post market since 2025-06-27 — choose a marketed DIN from the same-category list.
Other drugs in the same formulary class (08:12:12 Erythromycins) and how they are covered
Matched class: 08:12:12 Erythromycins
Drug-class inventory only. Lists recorded Ontario formulary products, not every Canadian medication; does not recommend treatment.
Some products covered without a code (check the product listing): CLARITHROMYCIN, ERYTHROMYCIN BASE, ERYTHROMYCIN ESTOLATE, ERYTHROMYCIN ETHYLSUCCINATE
08:12:12 Erythromycins
· 25 products · General benefit; DIN status E (meaning unconfirmed); confirm discontinuation/availability with Health Canada (1), General benefit (15), Off-Formulary Interchangeable, not an ODB benefit (9) · strengths: 500mg, 125mg/5mL, 250mg/5mL, 250mg · ER Tab, Ped Gran, Susp, Tab
From Health Canada product monographs; label wording only, not a treatment recommendation.
Matching is lexical and uses one held product label per generic; formulations and qualifying criteria may differ.
No displayed matched alternative is a general benefit.
RIFABUTIN · Limited Use, codes 103, 104 (1), Temporary benefit (1)
•
the prevention of disseminated Mycobacterium avium complex (MAC) disease in
patients with advanced HIV infection (CD4+ cell count 200/mm3 with an AIDS defining
diagnosis, or CD4+ cell count 100/mm3 without an AIDS defining diagnosis).
PM: https://pdf.hres.ca/dpd_pm/00073866.PDF; date SEPT 24, 2003; DIN 02063786; fetched 2026-09-10
Product monograph
Coverage source: ON formulary extract 2026-08-26
What the Health Canada label says it is for
1. Indications
pms-AZITHROMYCIN (azithromycin) is indicated in adults for treatment of mild to moderate
infections caused by susceptible strains of the designated microorganisms in the following
diseases and specific conditions. As recommended dosages, durations of therapy, and
applicable patient populations vary among these infections, see 4 Dosage and Administration
for specific dosing recommendations.
Because some strains are resistant to azithromycin, when applicable, appropriate culture and
susceptibility tests should be initiated before treatment to determine the causative organism
and its susceptibility to azithromycin. Therapy with pms-AZITHROMYCIN may be initiated
before results of these tests are known; once the results become available, antibiotic treatment
should be adjusted accordingly.
Pharyngitis and tonsillitis caused by Streptococcus pyogenes (group A β-hemolytic streptococci)
occurring in individuals who cannot use first line therapy.
NOTE: Penicillin is the usual drug of choice in the treatment of Streptococcus pyogenes
pharyngitis, including the prophylaxis of rheumatic fever. Azithromycin is often effective in the
eradication of susceptible strains of strep…
https://pdf.hres.ca/dpd_pm/00085669.PDF
PM date: AUG 7, 2026
Source product: PMS-AZITHROMYCIN; DIN 02261634; fetched 2026-09-10
Product monograph posted by Health Canada; excerpt for lookup only.
Availability
Novo-Azithromycin · DIN 02267845
Shortage status: discontinued (2025-04-07, reported by TEVA CANADA LIMITED); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02267845
Zithromax · DIN 02223716
Shortage status: active shortage (reported not recorded, last updated 2023-01-30) — report may be stale, confirm; reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02223716
Health Canada defines dormant products as: “products that were previously marketed in Canada but for which the manufacturer has suspended sale for period of at least 12 months.” (canada.ca, Sep 10, 2026 ↗)
Other review policies
For Zithromax: no applicable EAP criteria are held and no ODB benefit is established. These policies do not establish coverage.
For rare, immediately life-, limb- or organ-threatening circumstances, the Compassionate Review Policy may consider an unfunded drug or indication, subject to its criteria and without bypassing the drug review process. Compassionate Review Policy
Compassionate Review Policy: source quote
Where there are rare clinical circumstances in immediately life, limb, or organ-threatening conditions, the Executive Officer will also consider requests for drugs or indications in situations where there has not been a decision by the Executive Officer to provide funding of the drug or indication as part of the Ontario Drug Benefit program (and the EAP), and the drug or indication requested would not circumvent the established review process for new drugs or indications as part of the drug submission process for listing within the Ontario Drug Benefit program. Requests must meet the criteria for the Compassionate Review Policy.
For cancer drugs, Case-by-Case Review considers rare, immediately life-threatening circumstances when no satisfactory funded treatment exists; its criteria and application process apply. Case-by-Case Review (cancer drugs)
Case-by-Case Review (cancer drugs): source quote
Note: Requests for cancer drugs are considered under the Case-by-Case Review Program (CBCRP) which is administered by Ontario Health (Cancer Care Ontario) on behalf of the Ministry of Health. The CBCRP considers funding requests for drugs (both oral therapies and injectable drugs) for the treatment of cancer in patients who have a rare clinical circumstance that is immediately life-threatening (death is likely within a matter of months) and who require treatment with an unfunded drug, because there is no other satisfactory and funded treatment. Please refer to the Ontario Health website for information on the application process, FAQs, eligibility criteria and program policies.